US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic, in the latest effort by the Biden administration targeting pharmaceutical industry practices that drive up prices. The Federal Trade...